Publication:
Infliximab therapy in an infant with Netherton Syndrome

No Thumbnail Available

Date

2021-04-22

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Research Projects

Organizational Units

Journal Issue

Abstract

We present a patient with Netherton syndrome and severe skin manifestations treated with infliximab. By 6 months of age, the child had intractable pruritus, scaling, dry skin, and generalized eczematous lesions resistant to conventional therapies for atopic dermatitis. Clinical improvement was observed following the third infusion of infliximab, and by 12 months of age, the skin lesions completely resolved. Infliximab is a promising option for the management of skin inflammation in Netherton syndrome, even in infants.

Description

Keywords

Childhood, Ichthyosis, Nfliximab, Netherton syndrome, Tumor necrosis factor&#8208, Dermatology, Pediatrics

Citation

Collections


Metrikler

Search on Google Scholar


Total Views

1

Total Downloads

0